Literature DB >> 118803

Pharmacokinetic model for 2-amino-1,3,4-thiadiazole in mouse, dog, and monkey.

F G King, R L Dedrick.   

Abstract

A mathematic model has been developed to describe the time course of 2-amino-1,3,4-thiadiazole and its metabolites in the serum and tissues of mice, dogs, and monkeys. A flow-limited physiologic model has been used. The rate of metabolism in mice is described as a linear process; metabolism in dogs and monkeys is kinetically saturable. The urinary excretion in mice, dogs, and monkeys is described as a linear process; however, the kidney clearance in monkeys may decrease at high plasma concentrations. The model predictions are compared with published data. The kidney clearances of 2-amino-1,3,4-thiadiazole and its metabolites exhibit approximately a 0.7-power dependence on body weight when the mouse is compared with the larger species.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 118803

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  6 in total

Review 1.  Progress and prospects for genetic modification of nonhuman primate models in biomedical research.

Authors:  Anthony W S Chan
Journal:  ILAR J       Date:  2013

2.  Synthesis and biodistribution of Bowman-Birk soybean protease inhibitor conjugate with amphiphilic polyester.

Authors:  N I Larionova; I P Gladysheva; O V Polekhina; L P Kurochkina; E N Gorbatova
Journal:  Appl Biochem Biotechnol       Date:  1996 Oct-Nov       Impact factor: 2.926

3.  Physiological pharmacokinetic parameters for cis-dichlorodiammineplatinum(II) (DDP) in the mouse.

Authors:  F G King; R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

4.  Physiologic model for the pharmacokinetics of 2'deoxycoformycin in normal and leukemic mice.

Authors:  F G King; R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

Review 5.  Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors:  G Powis; M M Ames; J S Kovach
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Implications of pharmacokinetic modeling in risk assessment analysis.

Authors:  R J Lutz; R L Dedrick
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.